Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
OrthoPediatrics management to meet virtually with BTIG » 07:32
09/07/22
09/07
07:32
09/07/22
07:32
KIDS

OrthoPediatrics

$47.61 /

+0.38 (+0.80%)

BTIG Medical Technology…

BTIG Medical Technology Analyst Zimmerman holds a virtual meeting with management on September 7.

ShowHide Related Items >><<
KIDS OrthoPediatrics
$47.61 /

+0.38 (+0.80%)

KIDS OrthoPediatrics
$47.61 /

+0.38 (+0.80%)

08/05/22 JMP Securities
OrthoPediatrics price target lowered to $70 from $77 at JMP Securities
08/05/22 Truist
OrthoPediatrics price target raised to $66 from $51 at Truist
07/18/22 BTIG
OrthoPediatrics price target lowered to $61 from $65 at BTIG
07/18/22 Stifel
OrthoPediatrics price target lowered to $50 from $57 at Stifel
KIDS OrthoPediatrics
$47.61 /

+0.38 (+0.80%)

  • 11
    Aug
Over a month ago
Conference/Events
OrthoPediatrics management to meet virtually with Truist » 07:48
08/16/22
08/16
07:48
08/16/22
07:48
KIDS

OrthoPediatrics

$56.48 /

+1.51 (+2.75%)

Virtual Meeting to be…

Virtual Meeting to be held on August 16 hosted by Truist.

ShowHide Related Items >><<
KIDS OrthoPediatrics
$56.48 /

+1.51 (+2.75%)

KIDS OrthoPediatrics
$56.48 /

+1.51 (+2.75%)

08/05/22 JMP Securities
OrthoPediatrics price target lowered to $70 from $77 at JMP Securities
08/05/22 Truist
OrthoPediatrics price target raised to $66 from $51 at Truist
07/18/22 BTIG
OrthoPediatrics price target lowered to $61 from $65 at BTIG
07/18/22 Stifel
OrthoPediatrics price target lowered to $50 from $57 at Stifel
KIDS OrthoPediatrics
$56.48 /

+1.51 (+2.75%)

  • 11
    Aug
Syndicate
OrthoPediatrics 750K share Spot Secondary priced at $55.00 » 08:02
08/11/22
08/11
08:02
08/11/22
08:02
KIDS

OrthoPediatrics

$56.41 /

+0.48 (+0.86%)

Piper Sandler and Stifel…

Piper Sandler and Stifel acted as joint book running managers for the offering.

ShowHide Related Items >><<
KIDS OrthoPediatrics
$56.41 /

+0.48 (+0.86%)

KIDS OrthoPediatrics
$56.41 /

+0.48 (+0.86%)

08/05/22 JMP Securities
OrthoPediatrics price target lowered to $70 from $77 at JMP Securities
08/05/22 Truist
OrthoPediatrics price target raised to $66 from $51 at Truist
07/18/22 BTIG
OrthoPediatrics price target lowered to $61 from $65 at BTIG
07/18/22 Stifel
OrthoPediatrics price target lowered to $50 from $57 at Stifel
KIDS OrthoPediatrics
$56.41 /

+0.48 (+0.86%)

  • 11
    Aug
Syndicate
OrthoPediatrics announces common stock, warrants offering » 16:07
08/10/22
08/10
16:07
08/10/22
16:07
KIDS

OrthoPediatrics

$56.52 /

+0.59 (+1.05%)

OrthoPediatrics Corp.…

OrthoPediatrics Corp. announced it has commenced an underwritten public offering of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock. OrthoPediatrics intends to use the net proceeds from this offering to invest in implant and instrument sets for consignment to their customers, to repay long-term debt payable to Squadron Capital, to fund research and development activities, to expand their sales and marketing programs and for working capital and general corporate purposes. Piper Sandler and Stifel are acting as lead bookrunning managers for the offering.

ShowHide Related Items >><<
KIDS OrthoPediatrics
$56.52 /

+0.59 (+1.05%)

KIDS OrthoPediatrics
$56.52 /

+0.59 (+1.05%)

08/05/22 JMP Securities
OrthoPediatrics price target lowered to $70 from $77 at JMP Securities
08/05/22 Truist
OrthoPediatrics price target raised to $66 from $51 at Truist
07/18/22 BTIG
OrthoPediatrics price target lowered to $61 from $65 at BTIG
07/18/22 Stifel
OrthoPediatrics price target lowered to $50 from $57 at Stifel
KIDS OrthoPediatrics
$56.52 /

+0.59 (+1.05%)

Recommendations
OrthoPediatrics price target lowered to $70 from $77 at JMP Securities » 09:22
08/05/22
08/05
09:22
08/05/22
09:22
KIDS

OrthoPediatrics

$54.00 /

+4.65 (+9.42%)

JMP Securities analyst…

JMP Securities analyst David Turkaly lowered the firm's price target on OrthoPediatrics to $70 from $77 but keeps an Outperform rating on the shares after its Q2 results. The analyst states that he continues to consider the company to be a differentiated participant in the largely underserviced pediatric-orthopedic industry, with the potential to achieve further penetration in its base markets and enter complementary, attractive orthopedic arenas.

ShowHide Related Items >><<
KIDS OrthoPediatrics
$54.00 /

+4.65 (+9.42%)

KIDS OrthoPediatrics
$54.00 /

+4.65 (+9.42%)

08/05/22 Truist
OrthoPediatrics price target raised to $66 from $51 at Truist
07/18/22 BTIG
OrthoPediatrics price target lowered to $61 from $65 at BTIG
07/18/22 Stifel
OrthoPediatrics price target lowered to $50 from $57 at Stifel
06/14/22 Piper Sandler
Piper says OrthoPediatrics' acquisition of Pega Medical fills a portfolio 'void'
KIDS OrthoPediatrics
$54.00 /

+4.65 (+9.42%)

Recommendations
OrthoPediatrics price target raised to $66 from $51 at Truist » 09:19
08/05/22
08/05
09:19
08/05/22
09:19
KIDS

OrthoPediatrics

$54.00 /

+4.65 (+9.42%)

Truist analyst Samuel…

Truist analyst Samuel Brodovsky raised the firm's price target on OrthoPediatrics to $66 from $51 and keeps a Buy rating on the shares. The company reported "solid" Q2 results and its management demonstrated "impressive confidence" in its ability to achieve and sustain revenue growth of over 20%, the analyst tells investors in a research note.

ShowHide Related Items >><<
KIDS OrthoPediatrics
$54.00 /

+4.65 (+9.42%)

KIDS OrthoPediatrics
$54.00 /

+4.65 (+9.42%)

07/18/22 BTIG
OrthoPediatrics price target lowered to $61 from $65 at BTIG
07/18/22 Stifel
OrthoPediatrics price target lowered to $50 from $57 at Stifel
06/14/22 Piper Sandler
Piper says OrthoPediatrics' acquisition of Pega Medical fills a portfolio 'void'
05/06/22 Truist
OrthoPediatrics price target lowered to $54 from $70 at Truist
KIDS OrthoPediatrics
$54.00 /

+4.65 (+9.42%)

Earnings
OrthoPediatrics sees FY 22 revenue $127M-$130M , consensus $124.45M  16:14
08/03/22
08/03
16:14
08/03/22
16:14
KIDS

OrthoPediatrics

$49.35 /

+1.63 (+3.42%)

 
ShowHide Related Items >><<
KIDS OrthoPediatrics
$49.35 /

+1.63 (+3.42%)

KIDS OrthoPediatrics
$49.35 /

+1.63 (+3.42%)

07/18/22 BTIG
OrthoPediatrics price target lowered to $61 from $65 at BTIG
07/18/22 Stifel
OrthoPediatrics price target lowered to $50 from $57 at Stifel
06/14/22 Piper Sandler
Piper says OrthoPediatrics' acquisition of Pega Medical fills a portfolio 'void'
05/06/22 Truist
OrthoPediatrics price target lowered to $54 from $70 at Truist
KIDS OrthoPediatrics
$49.35 /

+1.63 (+3.42%)

Earnings
OrthoPediatrics reports Q2 EPS (17c), consensus (21c) » 16:12
08/03/22
08/03
16:12
08/03/22
16:12
KIDS

OrthoPediatrics

$49.35 /

+1.63 (+3.42%)

Reports Q2 revenue…

Reports Q2 revenue $$32.9M , consensus $32.4M.

ShowHide Related Items >><<
KIDS OrthoPediatrics
$49.35 /

+1.63 (+3.42%)

KIDS OrthoPediatrics
$49.35 /

+1.63 (+3.42%)

07/18/22 BTIG
OrthoPediatrics price target lowered to $61 from $65 at BTIG
07/18/22 Stifel
OrthoPediatrics price target lowered to $50 from $57 at Stifel
06/14/22 Piper Sandler
Piper says OrthoPediatrics' acquisition of Pega Medical fills a portfolio 'void'
05/06/22 Truist
OrthoPediatrics price target lowered to $54 from $70 at Truist
KIDS OrthoPediatrics
$49.35 /

+1.63 (+3.42%)

Recommendations
OrthoPediatrics price target lowered to $61 from $65 at BTIG » 08:19
07/18/22
07/18
08:19
07/18/22
08:19
KIDS

OrthoPediatrics

$42.14 /

+0.21 (+0.50%)

BTIG analyst Ryan…

BTIG analyst Ryan Zimmerman lowered the firm's price target on OrthoPediatrics to $61 from $65 but keeps a Buy rating on the shares as part of a broader research note titled "Fear and Loathing in Medical Technology" previewing Q2 results in the sector. Hopes of a recovery this quarter were throttled by a confluence of nagging inflation, higher FX pressure, supply chain constraints, and patient reticence to seek elective surgery in some areas, the analyst tells investors in a research note, adding however that the market has already priced in these factors.

ShowHide Related Items >><<
KIDS OrthoPediatrics
$42.14 /

+0.21 (+0.50%)

KIDS OrthoPediatrics
$42.14 /

+0.21 (+0.50%)

07/18/22 Stifel
OrthoPediatrics price target lowered to $50 from $57 at Stifel
06/14/22 Piper Sandler
Piper says OrthoPediatrics' acquisition of Pega Medical fills a portfolio 'void'
05/06/22 Truist
OrthoPediatrics price target lowered to $54 from $70 at Truist
05/05/22 Piper Sandler
OrthoPediatrics price target lowered to $55 from $80 at Piper Sandler
KIDS OrthoPediatrics
$42.14 /

+0.21 (+0.50%)

Recommendations
OrthoPediatrics price target lowered to $50 from $57 at Stifel » 07:36
07/18/22
07/18
07:36
07/18/22
07:36
KIDS

OrthoPediatrics

$42.14 /

+0.21 (+0.50%)

Stifel analyst Rick Wise…

Stifel analyst Rick Wise lowered the firm's price target on OrthoPediatrics to $50 from $57 and keeps a Buy rating on the shares. Many of his targets had been based on multiples assigned well-before multiple economic and geopolitical headwinds pushed both market- and industry-wide share prices lower and he is adjusting his MedTech trading multiples ahead of Q2 earnings season, though Wise notes that his target changes "do not represent any fundamental shift in our positive long-term thinking for the MedTech industry or the potential for broad-based growth reacceleration."

ShowHide Related Items >><<
KIDS OrthoPediatrics
$42.14 /

+0.21 (+0.50%)

KIDS OrthoPediatrics
$42.14 /

+0.21 (+0.50%)

06/14/22 Piper Sandler
Piper says OrthoPediatrics' acquisition of Pega Medical fills a portfolio 'void'
05/06/22 Truist
OrthoPediatrics price target lowered to $54 from $70 at Truist
05/05/22 Piper Sandler
OrthoPediatrics price target lowered to $55 from $80 at Piper Sandler
03/03/22 Piper Sandler
OrthoPediatrics full year guidance achievable, says Piper Sandler
KIDS OrthoPediatrics
$42.14 /

+0.21 (+0.50%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.